Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Assessing the vascular effects of early erythropoietin use in pediatric renal transplant recipients

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Maiese K et al. (2005) New avenues of exploration for erythropoietin. JAMA 293: 90–95

    Article  CAS  Google Scholar 

  2. Aydin Z et al. (2007) New horizons in prevention and treatment of ischaemic injury to kidney transplants. Nephrol Dial Transplant 22: 342–346

    Article  Google Scholar 

  3. Peterson TE and Katusic ZS (2007) EPO tecting the endothelium. Br J Pharmacol 150: 823–825

    Article  CAS  Google Scholar 

  4. Fliser D et al. (2006) EPO: renoprotection beyond anemia correction. Pediatr Nephrol 21: 1785–1789

    Article  Google Scholar 

  5. Heeschen C et al. (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102: 1340–1346

    Article  CAS  Google Scholar 

  6. ClinicalTrials.gov (online 5 September 2005) PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation [http://clinicaltrials.gov/show/NCT00157300] (accessed 16 November 2007)

  7. Mukai Y et al. (2006) Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. J Clin Invest 116: 334–343

    Article  CAS  Google Scholar 

  8. Spaulding C et al. (2006) Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355: 1093–1104

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David M Briscoe.

Ethics declarations

Competing interests

DM Briscoe has received grant support from the Roche Organ Transplantation Research Foundation and Wyeth Pharmaceuticals, and he has served as a consultant to Praecis Pharmaceuticals and Wyeth Pharmaceuticals. S Pal declared no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Briscoe, D., Pal, S. Assessing the vascular effects of early erythropoietin use in pediatric renal transplant recipients. Nat Rev Nephrol 4, 136–137 (2008). https://doi.org/10.1038/ncpneph0707

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0707

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing